Halozyme Therapeutics (HALO) Says FDA Accepted Genentech's BLA For Subcutaneous Formulation of Rituximab
Go back to Halozyme Therapeutics (HALO) Says FDA Accepted Genentech's BLA For Subcutaneous Formulation of Rituximab| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 38.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.71 | 52 Week High | $18.39 | |||
| Open | $38.71 | 52 Week Low | $6.96 | |||
| Day High | $38.71 | P/E | N/A | |||
| Day Low | $38.71 | EPS | $-0.58 | |||
| Volume | 7 | |||||
| ShangPharma Corp. ADS (NYSE: SHP) | Delayed: 8.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.95 | 52 Week High | $26.30 | |||
| Open | $8.95 | 52 Week Low | $26.03 | |||
| Day High | $8.95 | P/E | N/A | |||
| Day Low | $8.95 | EPS | $0.00 | |||
| Volume | 1,942,335 | |||||
| Shire pic (NASDAQ: SHPG) | Delayed: 179.20 +101.90 (131.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $77.30 | 52 Week High | $219.52 | |||
| Open | $77.29 | 52 Week Low | $147.60 | |||
| Day High | $77.49 | P/E | N/A | |||
| Day Low | $179.20 | EPS | $0.00 | |||
| Volume | 302,425 | |||||
